Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q1 2026 Earnings Call Transcript
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q1 2026 Earnings Call Transcript May 12, 2026Acurx Pharmaceuticals, Inc. misses on earnings expectations.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 0 | $0 | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.02 | 24,631 | $25,000.47 | 27,708 | 2025-01-06 | Filing | |
| $1.02 | 24,631 | $25,000.47 | 137,183 | 2025-01-06 | Filing | |
| $1.02 | 49,261 | $49,999.92 | 1,097,458 | 2025-01-06 | Filing | |
| $1.02 | 9,852 | $9,999.78 | 22,352 | 2025-01-06 | Filing | |
| $1.02 | 49,261 | $49,999.92 | 1,010,196 | 2025-01-06 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 54,642 | $202,722 | 0% | |
| 2. | 31,099 | $115,377 | 0% | |
| 3. | 24,819 | $92,080 | 0% | |
| 4. | 16,205 | $60,121 | 0% | |
| 5. | 13,785 | $51,144 | 0.03% |